ROSELAND, NJ / ACCESSWIRE / October 5, 2021 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery...
WOBURN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has joined the Center...
Toronto-based company to provide vision-enhancing medical devices in Europe and in North AmericaTORONTO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Leading...
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second MemberSAN DIEGO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies,...
CAMBRIDGE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a...
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy...
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
DEERFIELD, Ill., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on...
Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology Presentation to include a discussion...
Mobile SmileShop on Wheels Expands Access to Premium, Affordable, Convenient Oral Care By Traveling to Remote Areas Across the US...
Anticipates Additional Follow-On OrdersFREDERICK, Md., Oct. 05, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global...
BOSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare pediatric liver disease company developing novel...
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both Antibody Discovery and Cell Line...
NEW YORK and SCOTTSDALE, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of...
SAN DIEGO, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...
NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (the “Company” or “Better Choice”), a pet...
Outlook Therapeutics senior leadership team to provide a company overview and participate on industry panel on Thursday, October 7, 2021ISELIN,...
HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
$2.7 Million in Annualized Revenues, 20% Adjusted EBITDA Margin Post Integration, Over 10,000 Unique Orders and Adds 590 Unique Referring...
Agreement Marks the Official Launch of Lanier, a Georgia-Based Biopharmaceutical Company Developing a Robust Portfolio of First-in-Class Antibody CandidatesBOGART, Ga.,...